MIM_number;Associated_disease;Gene name
603234;Pseudoxanthoma elasticum arterial calcification, generalized, of infancy, 2;ABCC6
603214;Methylmalonic aciduria and homocystinuria, cbl- type;ABCD4
106180;Renal tubular dysgenesis;ACE
171640;Spondyloenchondrodysplasia with immune dysregulation;ACP5
102620;Multisystemic smooth muscle dysfunction syndrome;ACTA2
102630;Baraitser-Winter syndrome 1;ACTB
102545;Megacystis-microcolon-intestinal hypoperistalsis syndrome, Visceral myopathy;ACTG2
604638;Focal Segmental Glomerulosclerosis 1;ACTN4
601284;Hereditary hemorrhagic telangiectasia;ACVRL1
604134;Thrombotic thrombocytopenic purpura, familial;ADAMTS13
604417;CHOPS syndrome;AFF4
603100;Lipodystrophy congenital generalized, type 1;AGPAT2
106150;Renal tubular dysgenesis;AGT
106165;Renal tubular dysgenesis;AGTR1
604285;Hyperoxaluria, primary, type 1;AGXT
608894;Joubert Syndrome 3;AHI1
608103;Polycystic liver disease 3 with or without kidney cysts;ALG8
606941;Gillessen-Kaesbach-Nishimura sundrome (GIKANIS), Congenital disorder of glycosylation, type 2;ALG9
606844;Alstrom syndrome;ALMS1
171760;Hypophosphatasia, infantile;ALPL
300647;Osteopathia striata with cranial sclerosis;AMER1
605799;Megaloblasticanemia1-norwegian_type;AMN
615370;Nephronophthisis 16;ANKS6
616027;Focal Segmental Glomerulosclerosis 8;ANLN
300836;Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1);ANOS1
602242;Hypocalciuric hypercalcemia, familial type 3;AP2S1
612034;Sotos syndrome;APC2
107680;Amyloidosis, familial visceral, 3 or more types;APOA1
616003;Mitochondrial Complex 4 deficiency;APOPT1
102600;Adenine phosphoribosyltransferase deficiency;APRT
107777;Diabetes insipidus, nephrogenic;AQP2
601925;Nephrotic syndrome type 8;ARHGDIA
603024;Coffin-Siris syndrome;ARID1A
614556;Coffin-Siris syndrome;ARID1B
608922;Nephronophtisis, Joubert syndrome 8;ARL13B
608845;Bardet-biedl syndrome 3;ARL6
615549;Cushing syndrome due to macronodular adrenal hyperplasia;ARMC5
606036;Webb-Dattani syndrome;ARNT2
300382;Proud syndrome;ARX
612990;Bohring-Opitz syndrome;ASXL1
605239;Renal tubular acidosis, distal;ATP6V0A4
192132;Renal tubular acidosis with deafness;ATP6V1B1
300011;Occipital horn syndrome;ATP7A
606882;Wilson Disease;ATP7B
600529;3-methylglutaconic aciduria, type I;AUH
192340;Diabetes insipidus, neurohypophyseal;AVP
300538;Nephrogenic syndrome of inappropriate diuresis Diabetes insipidus, nephrogenic;AVPR2
109700;Amyloidosis, familial visceral;B2M
610308;Peters-plus syndrome;B3GLCT
605517;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13;B4GAT1
614144;Meckel syndrome, Meckel-Gruber syndrome type 9;B9D1
611951;Meckel syndrome type 10;B9D2
613605;Bardet-Biedl syndrome 18;BBIP1
209901;Bardet-Biedl syndrome 1;BBS1
610148;Bardet-Biedl syndrome 10;BBS10
610683;Bardet-Biedl syndrome 12;BBS12
606151;Bardet-Biedl syndrome 2;BBS2
600374;Bardet-Biedl Syndrome 4;BBS4
603650;Bardet-Biedl Syndrome 5;BBS5
607590;Bardet-Biedl syndrome 7;BBS7
607968;Bardet-Biedl syndrome 9;BBS9
300485;Microphthalmia, Lenz type, Microphthalmia, syndromic 2;BCOR
603647;Mitochondrial complex 3 deficiency, nuclear type 1;BCS1L
112262;Microphthalmia, syndromic 6;BMP4
608699;Diaphanospondylodysostosis;BMPER
164757;Noonan syndrome with multiple lentigines, Cardiofaciocutaneous syndrome;BRAF
605882;Fanconi anemia;BRIP1
606158;Lipodystrophy congenital generalized, type 2;BSCL2
606412;Bartter Syndrome, Type 4a, neonatal;BSND
602860;Mosaic variegated aneuploidy syndrome 1;BUB1B
120550;C1q Deficiency;C1QA
120570;C1q Deficiency;C1QB
120575;C1q Deficiency;C1QC
613927;C2 Deficiency;C2
120700;Complement component 3 deficiency;C3
120810;Complement component 4A deficiency;C4A
614571;Orofaciodigital syndrome 6;C5orf42
611492;Osteopetrosis with renal tubular acidosis;CA2
114208;Hypokalemic periodic paralysis, hokpp;CACNA1S
114010;Congenital disorder of glycosylation, type Iz;CAD
601762;Autoimmune Lymhoproliferative syndrome type 2A;CASP10
601199;Neonatal severe primary hyperparathyroidism, Hypocalcemia with Bartter syndrome;CASR
612013;Joubert syndrome with hepatic defect, Joubert syndrome with oculorenal defect, Meckel Syndrome 6, Joubert syndrome 9, COACH syndrome;CC2D2A
612753;Hennekam Lymphangiectasia-Lymphedema Syndrome;CCBE1
300859;3C syndrome;CCDC22
602243;Nephropathy with pretibial epidermolysis bullosa and deafness;CD151
107265;Immunodeficiency, common variable, 3;CD19
186845;Immunodeficiency, common variable, 6;CD81
606037;C syndrome;CD96
602868;Congenital Anomalies of the Kidney and the Urinary Tract;CDC5L
607393;Hyperparathyroidism 2;CDC73
600778;Multiple endocrine neoplasia, type 4;CDKN1B
600856;Beckwith-wiedemann syndrome, IMAGE syndrome;CDKN1C
607575;Sneddon syndrome Polyarteritis nodosa, childhood-onset;CECR1
600236;Stromme syndrome;CENPF
616690;Joubert syndrome 25;CEP104
613446;Short-rib thoracic dysplasia 13 with or without polydactyly;CEP120
614848;Senior-Loken syndrome, Nephronopthisis 15;CEP164
610142;Joubert syndrome with oculorenal defect, Bardet-biedl syndrome 14, Joubert Syndrome 5, Meckel syndrome 4, Senior-Loken Syndrome 6;CEP290
610523;Joubert's syndrome type 15;CEP41
615847;Nephronophthisis 18;CEP83
134370;Complement factor h deficiency;CFH
608593;Nephropathy due to CFHR5 deficiency;CFHR5
217030;Complement factor I deficiency;CFI
608892;CHARGE syndrome;CHD7
118494;Prune belly syndrome, Eagle-barrett syndrome;CHRM3
608429;Ehlers-Danlos syndrome, musculocontractural type 1;CHST14
611507;Wolfram syndrome 2;CISD2
300008;Dent disease nephrolithiasis type 1 hypophosphatemic Rickets;CLCN5
602024;Bartter's Syndrome Type 4b, Neonatal;CLCNKA
602023;Bartter syndrome, type 3 and type 4b;CLCNKB
603959;Hypomagnesemia 3, renal;CLDN16
610036;Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement, Hypomagnesemia 5, renal, with ocular involvement;CLDN19
607803;Hypomagnesemia type 6 Hypomagnesemia, seizures, and mental retardation;CNNM2
120328;Knobloch syndrome;COL18A1
120130;Hereditary angiopathy with nephropathy, aneurysms and Msucle cramps (HANAC);COL4A1
120070;Alport syndrome;COL4A3
120131;Alport syndrome, nephrotic syndrome (FSGS 1);COL4A4
303630;Alport syndrome;COL4A5
120215;Ehlers-Danlos syndrome, classic type;COL5A1
601924;Autoimmune interstitial lung, joint, and kidney disease;COPA
609825;Coenzyme q10 deficiency;COQ2
614647;Coenzyme Q10 deficiency, primary, 6;COQ6
601683;Coenzyme Q10 deficiency, primary, 8;COQ7
615567;Nephrotic syndrome, type 9;COQ8B
612837;Coenzyme Q10 deficiency, primary, 5;COQ9
602125;Mitochondrial Complex  4 deficiency;COX10
614478;Mitochondrial Complex 4 deficiency;COX14
614698;Mitochondrial Complex 4 deficiency;COX20
124089;Mitochondrial Complex 4 deficiency;COX6B1
300885;Linear skin defects with multiple congenital anomalies 2;COX7B
123870;Mitochondrial Complex 4 deficiency;COX8A
600528;Carnitine palmitoyl transferase 1A deficiency;CPT1A
600650;Lethal neonatal carnitine palmitoyltransferase 2 deficiency;CPT2
609720;FSGS 9 Ventriculomegaly with cystic kidney disease;CRB2
600140;Rubinstein Taybi syndrome type 1;CREBBP
605497;Osteogenesis imperfecta, type 7;CRTAP
611654;Meckel syndrome, Joubert syndrome 21;CSPP1
613129;Dyskeratosis congenita;CTC1
606272;Cystinosis, nephropathic cystinosis, late-onset juvenile or adolescent nephropathic;CTNS
602997;Megaloblastic anemia 1-finnish type;CUBN
603136;Pseudohypoaldosteronism, type 2e;CUL3
118485;46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency syndrome, Inherited isolated adrenal insufficiency due to CYP11A1 deficiency;CYP11A1
610613;Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency;CYP11B1
609300;17-alpha-hydroxylase17,20-lyasedeficiency;CYP17A1
613815;Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, Hyperandrogenism, nonclassic type, due to 21- hydroxylase deficiency;CYP21A2
126065;Hypercalcemia infantile, 1;CYP24A1
605755;Nephronophthisis 19;DCDC2
603057;Van Maldergem syndrome 1;DCHS1
615464;Orofaciodigital syndrome V;DDX59
601440;Nephrotic syndrome type 7;DGKE
602858;Smith-Lemli-Opitz Syndrome;DHCR7
614184;Perlman's syndrome (nephroblastomatosis, gigantism);DIS3L2
300126;Dyskeratosis Congenita, X-linked;DKC1
300189;Mental retardation, x-linked 90;DLG3
602768;Autosomal recessive spondylocostal dysostosis;DLL3
605185;Adams-Oliver syndrome 6;DLL4
601911;Orofacial cleft 15;DLX4
600980;Hypophosphataemic rickets;DMP1
601810;Seckel syndrome 8;DNA2
613190;Ciliary dyskinesia, primary, 13;DNAAF1
602244;Systemic Lupus Erythematosus 16;DNASE1L3
602900;Immunodeficiency-centromeric instability, facial anomalies syndrome 1, icf1;DNMT3B
603527;Developmental delay with short stature, dysmorphic features, and sparse hair;DPH1
612666;Congenital Anomalies of the Kidney and the Urinary Tract;DSTYK
603297;Short rib-polydactyly syndrome, Verma-Naumoff type, Short rib-polydactyly syndrome (Jeune's syndrome) type 3;DYNC2H1
300205;Chondrodysplasia punctata;EBP
131243;Mandibulfacial dysostosis with alopecia;EDNRA
604633;Cutis laxa type 1;EFEMP2
131530;Hypomagnesemia 4, renal;EGF
607037;Fanconi renotubular syndrome 3;EHHADH
604032;Wolcott-Rallison Syndrome;EIF2AK3
606687;Ovarioleukodystrophy, leukoencelpaly with vanishing white matter;EIF2B4
602334;Nephrotic syndrome type 10;EMP2
131195;Hereditary hemorrhagic telangiectasia;ENG
173335;Hypophosphataemicrickets;ENPP1
615068;Vici syndrome;EPG5
190151;Lethal congenital contracture syndrome 2;ERBB3
133520;Fanconi anemia, Xeroderma pigmentosum, type f, Cockayne syndrome;ERCC4
609413;Cockayne syndrome, type B;ERCC6
609412;Cockayne Syndrome, Type A;ERCC8
609353;Roberts syndrome;ESCO2
608053;Glutaric aciduria 2a;ETFA
130410;Glutaric acidemia 2b;ETFB
231675;Glutaric acidemia 2c;ETFDH
604831;Ellis Van Creveld syndrome;EVC
607261;Ellis Van Creveld syndrome;EVC2
601653;Branchio-oto-renal syndrome 1;EYA1
613871;tyrosinemia, type 1;FAH
611062;Amelogenesis imperfecta-nephrocalcinosis syndrome, Amelogenesis imperfecta type IG (enamel-renal syndrome);FAM20A
611061;Raine syndrome;FAM20C
300708;STAR (toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations);FAM58A
613534;Interstitial nephritis, karyomegalic;FAN1
607139;Fanconi anemia, complementation group a;FANCA
300515;Fanconi anemia, complementation group b;FANCB
613899;Fanconi anemia, complementation group c;FANCC
613984;Fanconi anemia, Complementation group d2;FANCD2
613976;Fanconi anemia, complementation group e;FANCE
613897;Fanconi anemia;FANCF
602956;Fanconi anemia;FANCG
611360;Fanconi anemia, complementation group I;FANCI
608111;Fanconi anemia, complementation group L;FANCL
609644;Fanconi anemia;FANCM
612322;Mitochondrial Complex 4 deficiency;FASTKD2
612411;Van Maldergem Syndrome 2 Hennekam lymphangiectasia- lymphedema syndrome 2;FAT4
604580;Cutis laxa type IA;FBLN5
605654;Mitochondrial DNA depletion syndrome 13;FBXL4
134820;Amyloidosis, familial visceral, hereditary renal;FGA
602115;Lacrimoauriculodentodigital syndrome;FGF10
605558;Renal hypodysplasiaaplasia 2;FGF20
605380;Hypophosphatemic Rickets, autosomal dominant Tumoral Calcinosis, hyperphosphatemic, familial;FGF23
136350;Encephalocraniocutaneous Lipomatosis, Kallmann syndrome 2, kal2;FGFR1
176943;Pfeiffer syndrome type 3, Antley-Bixler syndrome, Apert syndrome, LADD syndrome;FGFR2
134934;Thanatophoric dysplasia type 1, Thanatophoric dysplasia type;FGFR3
614505;Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss;FKBP14
607273;Birt-Hogg-Dube Syndrome;FLCN
300017;Congenital short bowel syndrome Melnick-Needles syndrome Otopalatodigital syndrome, type 2, Frontometaphyseal Dysplasia;FLNA
603381;Spondylocarpotarsal synostosis syndrome;FLNB
136352;Lymphedema, hereditary, IA;FLT4
135600;Glomerulopathy with fibronectin deposits 2;FN1
601090;Axenfeld-Rieger syndrome, Type 3;FOXC1
602402;Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus;FOXC2
601089;Alveolar capillary dysplasia with misalignment of pulmonary veins, acdmpv;FOXF1
607830;Fraser syndrome;FRAS1
608944;Bifid nose with or without anorectal and renal anomalies;FREM1
608945;Fraser syndrome;FREM2
610622;Caudal regression sequence;FUZ
601814;Hypomagnesemia 2, renal;FXYD2
613742;Glycogen storage disease Ia;G6PC
601756;Tumoral calcinosis, hyperphosphatemic, familial, hftc;GALNT3
131320;Hypoparathyroidism, deafness, renal disease syndrome;GATA3
601656;Pancreatic agenesis and congenital heart defects;GATA6
606463;Gaucher disease;GBA
608801;Glutaricaciduria, type I;GCDH
603716;Hypoparathyroidism, familial isolated;GCM2
605120;Hereditary hemorrhagic telangiectasia;GDF2
600837;Congenital Anomalies of the Kidney and the Urinary Tract;GDNF
300644;Fabry Disease;GLA
611458;GM1-gangliosidosis, type 1, type 2;GLB1
165240;Pallister-Hall syndrome;GLI3
608539;Nephronophthisis 7;GLIS2
610192;Diabetes Mellitus, Neonatal, With Congenital Hypothyroidism;GLIS3
139313;Hypocalciuric hypercalcemia, type 2;GNA11
139320;pseudohypoparathyroidism, type 1B;GNAS
610540;pseudohypoparathyroidism, type 1B;GNASGAS1
139380;Mental retardation, autosomal dominant 42;GNB1
300037;Simpson golabi behmel syndrome type 1;GPC3
604296;Hyperoxaluria, primary, type 2;GRHPR
604597;Fraser syndrome;GRIP1
137350;Amyloidosis, Finnish type cerebral amyloid angiopathy, GSN- related;GSN
141900;Sickle Cell Anemia beta-thalassemia, dominant inclusion body type;HBB
300269;Cornelia de Lange syndrome;HDAC8
608059;Autosomal recessive spondylocostal dysostosis;HES7
607474;Alkaptonuria;HGD
142410;Diabetes mellitus, insulin-dependent, 20, MODY, type 3, Renal cell carcinoma;HNF1A
189907;Renal Cysts and Diabetes Syndrome;HNF1B
600281;Renal cysts and diabetes syndrome, Hyperinsulinism due to HNF4A deficiency, Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young;HNF4A
613597;Primary hyperoxaluria type 3;HOGA1
142959;Hand-foot-uterus syndrome;HOXA13
142989;Vacterl association with hydrocephalus;HOXD13
308000;Kelley-Seegmiller Syndrome Lesch-Nyhan Syndrome;HPRT1
604982;Hermansky-Pudlak syndrome 1;HPS1
613469;Ochoa syndrome, Urofacial syndrome 1;HPSE2
190020;Costello syndrome;HRAS
614232;Apparent mineralocorticoid excess;HSD11B2
605573;46,XY disorder of sex development due to 17-beta- hydroxysteroid dehydrogenase 3 deficiency;HSD17B3
601860;D-bifunctional protein deficiency;HSD17B4
613890;Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency;HSD3B2
600548;Even-plus syndrome;HSPA9
142461;Schwartz-Jampel syndrome;HSPG2
610693;Hydrolethalus syndrome;HYLS1
612325;Endocrine-cerebroosteodysplasia;ICK
606045;Cranioectodermal dysplasia type 1;IFT122
614620;Short rib-polydactyly syndrome (Jeune's syndrome) type 9;IFT140
607386;Bardet-Biedl syndrome, Short rib-polydactyly syndrome (Jeune's syndrome) type 10;IFT172
615870;Bardet-Biedl syndrome 19;IFT27
614068;Cranioectodermal dysplasia type 3;IFT43
611177;Short rib-polydactyly syndrome, Verma-Naumoff type;IFT80
603722;Familial dysautonomia, Hereditary sensory and autonomic neuropathy type 3, hsan3;IKBKAP
610982;Focal Segmental Glomerulosclerosis 5 Charcot-Marie-Tooth disease E;INF2
613037;Joubert syndrome with hepatic defectJoubert Syndrome 1;INPP5E
600829;Opsismodysplasia;INPPL1
147670;Rabson-Mendenhall syndrome;INSR
243305;Senior-Loken syndrome, Nephronophthisis 2, infantile;INVS
609237;Senior-loken syndrome 5;IQCB1
607199;Popliteal pterygium syndrome 1;IRF6
605025;Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital;ITGA3
147556;Junctional epidermolysis bullosa-pyloric atresia syndrome, Epidermolysis bullosa, junctional, with pyloric stenosis;ITGA6
604063;Renal hypodysplasia-aplasia 1;ITGA8
147557;Epidermolysis bullosa, junctional, with pyloric atresia;ITGB4
601920;Alagille syndrome type 1;JAG1
606871;Hemorrhagic destruction of the brain, subependymal calcification, and cataracts;JAM3
607704;Nephroticsyndrome;KANK1
614610;Palmoplantar keratoderma and woolly hair;KANK2
614612;Nephrotic syndrome;KANK4
612452;Koolen-De Vries Syndrome;KANSL1
605880;Genitopatellar syndrome;KAT6B
176260;Hypomagnesemia associated with myokymia;KCNA1
603305;Zimmermann-Laband syndrome 1;KCNH1
600359;Bartter's syndrome, type 2;KCNJ1
602208;Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (sesame syndrome);KCNJ10
600734;Hyperaldosteronism,familial,type 3;KCNJ5
613420;Scalp-Ear-Nipple Syndrome;KCTD1
609132;Cleft palate, psychomotor retardation, and distinctive facial features;KDM1A
300128;Kabuki syndrome;KDM6A
611279;Meckel syndrome 12;KIF14
611254;Acrocallosal syndrome;KIF7
604824;Tumoral calcinosis, hyperphosphatemic;KL
605775;Pseudohypoaldosteronism, type 2d;KLHL3
602113;Kabuki syndrome 1;KMT2D
190070;Cardiofaciocutaneous syndrome;KRAS
605197;Hydroxykynureninuria;KYNU
150325;Nephrotic syndrome, type 5, with or without ocular abnormalities Pierson Syndrome;LAMB2
150310;Amelogenesis imperfecta, type IA, Epidermolysis bullosa, junctional, Herlitz type, Epidermolysis bullosa, junctional, non- Herlitz type;LAMB3
150292;Epidermolysis bullosa, junctional, Herlitz type, Epidermolysis bullosa, junctional, non-Herlitz type;LAMC2
151350;Infantile liver failure syndrome 1;LARS
606967;Norum disease;LCAT
150000;Glycogen storage disease XI;LDHA
602576;Autosomal recessive spondylocostal dysostosis;LFNG
612625;Methylmalonic aciduria and homocystinuria, cblF type;LMBRD1
150330;Atypical Werner syndrome Laminopathy type Decaudain- Vigouroux LMNA-related cardiocutaneous progeria syndrome, Restrictive Dermopathy, Lethal;LMNA
602575;Nail-patella syndrome;LMX1B
605490;CODAS syndrome;LONP1
605518;Myoglobinuria, acute recurrent;LPIN1
608869;Ochoa syndrome, Urofacial Syndrome 2;LRIG2
600073;Donnai-barrow syndrome;LRP2
604270;Cenani-lenz syndactyly syndrome;LRP4
604710;Cutis laxa, autosomal recessive, type IC;LTBP4
153450;Amyloidosis, familial visceral, renal;LYZ
606568;Bardet Biedl syndrome type 17;LZTFL1
608968;Multicentric carpo-tarsal osteolysis with or without nephropathy;MAFB
300470;Bartter syndrome, type 5, antenatal, transient;MAGED2
176872;Cardiofaciocutaneous syndrome;MAP2K1
601263;Cardiofaciocutaneous syndrome;MAP2K2
605789;Symmetric circumferential skin creases congenital, 2;MAPRE2
300294;IFAP Syndrome with or without Bresheck Syndrome;MBTPS2
608107;Familial Mediterranean fever;MEFV
605195;Autosomal recessive spondylocostal dysostosis;MESP2
609415;Feingold syndrome 2, Brachydactyly with short stature and microcephaly;MIR17HG
604896;Bardet-biedl syndrome 6, McKusick-Kaufman syndrome;MKKS
609883;Meckel syndrome 1, Bardet-Biedl syndrome 13;MKS1
120436;Muir-Torre syndrome;MLH1
609831;Methylmalonic aciduria and homocystinuria, cblc type;MMACHC
142994;Currarino syndrome;MNX1
605810;Combined oxidative phosphorylation deficiency 5;MRPS22
609309;Muir-Torre syndrome colorectal cancer, hereditary, nonpolyposis, type 1;MSH2
600678;Muir-Torre syndrome;MSH6
300415;Myotubular myopathy;MTM1
158340;Medullary cystic kidney disease 1;MUC1
609058;Vitamin B12-unresponsive methylmalonic acidemia type mut0;MUT
251170;Mevalonic aciduria;MVK
164840;Feingold syndrome;MYCN
160775;Fechtner syndrome, Epstein Syndrome;MYH9
601479;Glomerulosclerosis, focal segmental, 6;MYO1E
300013;Microphthalmia, Lenz type, Microphthalmia, syndromic 1;NAA10
612803;Combined oxidative phosphorylation deficiency 24;NARS2
602667;Nijmegen breakage syndrome;NBN
600644;Cleft lip,palate-ectodermal dysplasia syndrome;NECTIN1
604588;Short rib-polydactyly syndrome (Jeune's syndrome) type 6;NEK1
609799;Nephronophthisis 9 Renal-heaptic-pancreatic dysplasia 2;NEK8
300524;Mental retardation, X-linked 98;NEXMIF
613113;Neurofibromatosis, type I;NF1
606470;Dyskeratosis congenita;NHP2
608667;Cornelia de lange syndrome type 1;NIPBL
606416;Muckle-wells syndrome Familial cold-induced inflammatory syndrome 1;NLRP3
600275;Acroosteolysis dominant type, Alagille syndrome 2, Hajdu- Cheney Syndrome;NOTCH2
600276;Infantile myofibromatosis, Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, Lateral meningocele syndrome;NOTCH3
607100;Bardet-Biedl syndrome, Nephronophthisis 1 (juvenile), Senior- Loken syndrome, Joubert syndrome 4;NPHP1
608002;Senior-Loken syndrome, Nephronophthisis 3 (adolescent), Meckel syndrome 7, Renal-hepatic-pancreatic dysplasia;NPHP3
607215;Nephronophthisis 4 Senior-Loken syndrome 4;NPHP4
602716;Congenital nephrotic syndrome, Finnish type;NPHS1
604766;Nephrotic syndrome type 2;NPHS2
300473;Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism;NR0B1
600983;Pseudohypoaldosteronism Type I, autosomal dominant Hypertension, Early-Onset, Autosomal Dominant, With Exacerbation in Pregnancy;NR3C2
606681;Sotos syndrome 1, Beckwith-Wiedemann syndrome, BWS;NSD1
300275;CHILD syndrome;NSDHL
607617;Nephrotic syndrome, type 11;NUP107
614352;Nephrotic syndrome, type 13;NUP205
614351;Nephrotic Syndrome, Type 12;NUP93
602876;Band-like calcification with simplified gyration and polymicogyria;OCLN
300535;Dent disease 2 Lowe syndrome;OCRL
300170;Joubert syndrome type 10, Orofaciodigital syndrome I, Golabi-Behmel syndrome, type 2;OFD1
614243;5-oxoprolinase deficiency;OPLAH
610506;Zellweger syndrome 3;PAF1
610355;Fanconi Anemia, Complementation Group N;PALB2
167409;Renal coloboma syndrome, FSGS 7, Papillorenal Syndrome, PAPRS;PAX2
608786;Pyruvate carboxylase deficiency;PC
602676;Joubert's syndrome type 22;PDE6D
607429;Coenzyme Q10 deficiency, primary, 2;PDSS1
610564;Coenzyme q10 deficiency, primary, 3;PDSS2
614770;Mitochondrial Complex 4 deficiency;PET100
602136;Zellweger syndrome;PEX1
602859;Zellweger syndrome;PEX10
603867;Zellweger syndrome;PEX11B
601758;Zellweger syndrome;PEX12
601789;Zellweger syndrome;PEX13
601791;Zellweger syndrome;PEX14
603360;Zellweger syndrome;PEX16
600279;Zellweger syndrome;PEX19
170993;Zellweger syndrome;PEX2
608666;Zellweger syndrome;PEX26
603164;Zellweger syndrome;PEX3
600414;Zellweger syndrome;PEX5
601498;Zellweger syndrome;PEX6
311800;Phosphoglycerate kinase 1 deficiency;PGK1
172100;Immunodeficiency 23;PGM3
300550;Hypophosphatemic rickets;PHEX
606879;Neu-Laxova syndrome 1;PHGDH
613629;Marden-Walker Syndrome;PIEZO2
311770;Multiple Congenital anomalies-hypotonia-seizures syndrome 2;PIGA
605947;CHIME syndrome;PIGL
606097;Multiple congenital anomalies-hypotonia-seizures syndrome 1;PIGN
610272;Multiple congenital anomalies-hypotonia-seizures syndrome 3;PIGT
171834;Cowden syndrome;PIK3CA
603157;Megalencephaly-polymicogyria-polydactyly-hyodrcephalus syndrome 1;PIK3R2
601542;Axenfeld-Rieger syndrome, type 1, Iridogoniodysgenesis, type 2, Peters anomaly, Ring dermoid of cornea;PITX2
601313;Polycystic kidney disease 1;PKD1
173910;Polycystic kidney disease 2;PKD2
606702;Autosomal recessive polycystic kidney disease, Polycystic and hepatic disease;PKHD1
608414;Nephrotic syndrome type 3;PLCE1
173350;Plasminogen deficiency, Type I;PLG
153454;Ehlers-Danlos syndrome, type 6;PLOD1
601785;Congenital disorder of glycosylation, type Ia;PMM2
603197;Laurence-Moon syndrome;PNPLA6
176830;Obesity, adrenal insufficiency, and red hair due to POMC deficiency;POMC
607423;Muscular dystrophy-dystroglycanopathy, type A, 1;POMT1
124015;Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Antley-Bixler Syndrome with Genital Anomalies and Disordered Steroidogenesis;POR
300651;Focal dermal hypoplasia;PORCN
613257;Microcephaly, short stature, and impaired glucose metabolism 2;PPP1R15B
300463;Renpenning Syndrome 1;PQBP1
176977;Autoimmune lymphoproliferative syndrome, type 2;PRKCD
606810;Hyperprolinemia, type I;PRODH
607123;Kallmann syndrome 3, kal3 (hypogonadotropic hypogonadism 3 with or without anosmia);PROKR2
311850;Phosphoribosylpyrophosphate Synthetase Syperactivity;PRPS1
176801;Metachromatic leukodystrophy due to SAP-b deficiency;PSAP
601728;Cowden syndrome, VATER association with macrocephaly and ventriculomegaly;PTEN
168450;Hypoparathyroidism;PTH
168468;Metaphyseal chondrodysplasia, Murk -ansen type;PTH1R
176876;Noonan syndrome with multiple lentiginesLeopard syndrome 1;PTPN11
600579;Nephrotic syndrome, type 6;PTPRO
604819;Verheij syndrome;PUF60
608455;McArdle Disease;PYGM
602207;Micro syndrome;RAB18
606144;Carpenter syndrome;RAB23
602536;Micro syndrome;RAB3GAP1
609275;Micro syndrome;RAB3GAP2
602774;Fanconi anemia, complementation group O;RAD51C
607642;Smith-Magenis syndrome Yuan-Harel-Lupski syndrome;RAI1
179520;Kabuki syndrome;RAP1A
179530;Kabuki syndrome;RAP1B
604124;Seckel Syndrome 2;RBBP8
300080;TARP syndrome;RBM10
605313;Thrombocytopenia-absent radius syndrome;RBM8A
603780;Baller-gerold syndrome;RECQL4
179820;Renal tubular dysgenesis hyperuricemic nephropathy, familial juvenile 2;REN
605226;Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart;RERE
164761;Renal agenesis, bilateral;RET
610222;Macrocephaly, alopecia, cutis laxa, and scoliosis;RIN2
605706;Popliteal pterygium syndrome, Bartsocas-Papas type;RIPK4
609891;Autosomal recessive spondylocostal dysostosis;RIPPLY2
614917;Combined oxidative phosphorylation deficiency 11;RMND1
601428;Microcephalic osteodysplastic primordial dwarfism, type I;RNU4ATAC
602431;Vesicoureteral reflux 2;ROBO2
602337;Robinow syndrome;ROR2
610937;Meckel syndrome 5, Joubert syndrome 7, COACH syndrome;RPGRIP1L
604175;Diamond-Blackfan anemia 7;RPL11
603704;Diamond-Blackfan anemia 11;RPL26
180468;Blackfan-Diamond anemia;RPL35A
603634;Blackfan-Diamond anemia;RPL5
603632;Blackfan-Diamond anemia;RPS10
180472;Blackfan-Diamond anemia;RPS17
603474;Diamond-Blackfan anemia 1;RPS19
602412;Blackfan-Diamond anemia;RPS24
603701;Diamond-Blackfan anemia 10;RPS26
603685;Blackfan-Diamond anemia;RPS28
603633;Blackfan-Diamond anemia;RPS29
603658;Blackfan-Diamond anemia;RPS7
604712;Mitochondrial DNA depletion syndrome 8A;RRM2B
610436;Microsephaly, short stature, and polymicogyria with or without seizures;RTTN
602218;Townes-Brocks Branchiootorenal-like Syndrome;SALL1
607343;Acro-renal-ocular syndrome, Duane-Radial Ray Syndrome IVIC Syndrome;SALL4
612804;Hyperuricemia, pulmonary hypertension, renal failure and alkalosis;SARS2
607444;Shwachman-Diamond syndrome;SBDS
602286;Lathosterolosis;SC5D
602257;Epilepsy, Progressive Myoclonic, 4 with or without Renal Failure;SCARB2
603967;Hypokalemic periodic paralysis, hokpp type2;SCN4A
600228;Pseudohypoaldosteronism, Type I;SCNN1A
600760;Liddle syndrome;SCNN1B
600761;Pseudohypoaldosteronism, type 1, Liddle Syndrome;SCNN1G
603644;Mitochondrial Complex 4 deficiency;SCO1
613524;Senior loken syndrome type 7, Bardet-Biedl Syndrome 16;SDCCAG8
185470;Cowden Syndrome 2, Pheochormocytoma Paragangliomas 4;SDHB
602413;Cowden syndrome;SDHC
602690;Pheochromocytoma Cowden syndrome 3;SDHD
608166;Charge syndrome;SEMA3E
600943;Osteogenesis imperfecta, type X;SERPINH1
611060;Schinzel-Giedion Midface Retraction Syndrome;SETBP1
605593;Nager syndrome, Acrofacial dysostosis 1, Nager type;SF3B4
600725;Single median maxillary central incisor holoprosencephaly 3;SHH
609845;Sucrase-isomaltase deficiency, congenital;SI
601205;Branchio-oto-renal syndrome;SIX1
604994;Renal hypodysplasia;SIX2
600963;Branchio-oto-renal syndrome 2;SIX5
600839;Bartter syndrome, type 1, antenatal;SLC12A1
600968;Gitelman syndrome;SLC12A3
611910;Cataract, juvenile, with microcornea and glucosuria;SLC16A12
133550;Dicarboylic aminoaciduria;SLC1A1
607096;Hypouricemia, renal, 1, rhuc1;SLC22A12
190315;Combined D-2- and L-2-hydroxyglutaric aciduria;SLC25A1
605646;Pendred syndrome;SLC26A4
606145;Arterial tortuosity syndrome,ats;SLC2A10
138160;Fanconi-Bickel syndrome;SLC2A2
606142;Hypouricemia, renal, 2;SLC2A9
182309;Fanconi renotubular syndrome 2 hypercalcemia, infantile, 2 nephrolithiasis,osteoporosis, hypophosphatemic, 1;SLC34A1
609826;Hypophosphatemic rickets with hypercalciuria, hereditary;SLC34A3
608331;Hyperglycinuria;SLC36A2
602671;Glycogen storage disease Ib Ic;SLC37A4
104614;Cystinuria;SLC3A1
109270;Renal tubular acidosis, distal;SLC4A1
603345;Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation;SLC4A4
182381;Renal glucosuria;SLC5A2
608893;Hartnup Disorder Hyperglycinuria;SLC6A19
605616;Hyperglycinuria;SLC6A20
603593;Lysinuric protein intolerance;SLC7A7
604144;Cystinuria;SLC7A9
604990;Nephrolithiasis,osteoporosis, hypophosphatemic, 2;SLC9A3R1
603746;Congenital Anomalies of the Kidney and the Urinary Tract;SLIT2
613278;Fanconi anemia, complementation group P;SLX4
603109;Loeys-Dietz syndrome 3;SMAD3
606622;Schimke immuno-osseous dysplasiaSchimke's immunoosseous dystrophy;SMARCAL1
603111;Coffin-Siris syndrome;SMARCE1
300040;Cornelia de Lange syndrome;SMC1A
608488;Microphthalmia with limb anomalies;SMOC1
182282;Cerebrocostomandibular syndrome;SNRPB
600898;Mental retardation, autosomal dominant, 27;SOX11
610928;Vesicoureteral Reflux 3;SOX17
601618;Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome;SOX18
608160;Campomelic dysplasia;SOX9
614140;Opitz GBBB syndrome, type 2;SPECC1L
605124;Diarrhea 3, secretory sodium, congenital, syndromic;SPINT2
611421;Floating-Harbor syndrome;SRCAP
600617;Lipoid adrenal hyperplasia;STAR
602216;Peutz-Jeghers syndrome;STK11
610745;Microphthalmia, syndromic 9, mcops9;STRA6
608626;Polyhydramnios, megalencephaly, and symptomatic epilepsy;STRADA
607207;Spinocerebellar ataxia, autosomal recessive 16;STUB1
603666;Pseudohypoparathyroidism, type 1B;STX16
603921;Mitochondrial dna depletion syndrome, encephalomyopathic form, with methylmalonic aciduria;SUCLA2
609187;Glutaric aciduria 3;SUGCT
612958;Mitochondrial Complex 4 deficiency;TACO1
612758;Osteochondrodysplasia, complex lethal, Symoens-Barnes- Gistelinck type;TAPT1
611663;Micro syndrome;TBC1D20
613577;DOOR syndrome;TBC1D24
604934;Hypoparathyroidism-retardation-dysmorphism syndrome, Kenny-Caffey syndrome, type 1;TBCE
604613;Congenital hydronephrosisCongenital anomalies of Kidney and Urinary Tract 2;TBX18
613846;Meckel-gruber syndrome type 8, Joubert syndrome 24;TCTN2
613847;Joubert syndrome 18, Orofaciodigital syndrome 4;TCTN3
602322;Dyskeratosis congenita;TERC
107580;Branchiooculofacial Syndrome;TFAP2A
615403;Beaulieu-Boycott-Innes Syndrome;THOC6
614123;Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome;TMCO1
614459;Joubert syndrome 16;TMEM138
613277;Joubert syndrome 2, Meckel syndrome;TMEM216
614949;Joubert syndrome type 20, meckel-gruber syndrome type 11;TMEM231
614423;Joubert syndrome type 14;TMEM237
609884;Nephronophtisis 11, Meckel Syndrome 3, Joubert syndrome 6, COACH syndrome;TMEM67
612418;TMEM70-related mitochondrial encephalo-cardio-myopathy;TMEM70
191190;Autosomal dominant periodic fever syndrome;TNFRSF1A
600985;Vesicoureteral Reflux 8 Ehlers-Danlos syndrome due to tenascin-X deficiency;TNXB
603273;EEC syndrome, Ectrodactyly, ectodermal dysplasia, and cleft lip,palate syndrome 3;TP63
607380;Senior-Loken syndrome 9;TRAF3IP1
605958;Seckel syndrome 9;TRAIP
606219;Congenital Anomalies of the Kidney and the Urinary Tract;TRAP1
606609;HERNS syndrome, Vasculopathy, retinal, with cerebral leukodystrophy;TREX1
602290;Bardet-biedl syndrome 11;TRIM32
611023;Combined oxidative phosphorylation deficiency 26;TRMT5
612907;Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay;TRNT1
603652;Focal Segmental Glomerulosclerosis 2;TRPC6
607009;Hypomagnesemia 1, intestinal;TRPM6
605284;Tuberous Sclerosis-1;TSC1
191092;Tuberous sclerosis-2;TSC2
300945;Blackfan-Diamond anemia;TSR2
612014;Nephronophthisis 12;TTC21B
614589;Trichohepatonenteric syndrome 1;TTC37
608132;Bardet-Biedl Syndrome 8;TTC8
176300;Amyloidosis, hereditary, transthyretin-related;TTR
607556;Focal facial dermal dysplasia type 3;TWIST2
611595;Burn-McKeown syndrome;TXNL4A
610538;Fanconi anemia;UBE2T
605981;Johanson-Blizzard syndrome;UBR1
191845;Medullary cystic kidney disease 2 hyperuricemic nephropathy glomerulocystic kidney disease;UMOD
613891;Hereditary orotic aciduria;UMPS
606673;Beta-ureidopropionase deficiency;UPB1
611559;Renal hypodysplasia, urogenital dysplasia;UPK3A
614461;Mitochondrial complex 3 deficiency, nuclear type 7;UQCC2
300072;Mental retardation, X-linked 99, syndromic, female-restricted;USP9X
610132;Caudal regression syndrome;VANGL1
608537;Von Hippel-Lindau Syndrome;VHL
613401;Arthrogryposis, renal dysfunction, and cholestasis 2, arcs2;VIPAS39
608552;Arthrogryposis, renal dysfunction, and cholestasis 1, arcs1;VPS33B
300392;Wiskott-Aldrich syndrome;WAS
613580;Bardet-Biedl syndrome;WDPCP
608151;Senior-Loken syndrome, Short-rib thoracic dysplasia 5, Nephronophthisis type 13, Cranioectodermal dysplasia;WDR19
613363;Short rib-polydactyly syndrome, Verma-Naumoff typeShort-rib thoracic dysplasia 11 with or without polydactyly;WDR34
613602;Short rib-polydactyly syndrome, Verma-Naumoff type, Short rib-polydactyly syndrome (Jeune's syndrome) type 7, Cranioectodermal dysplasia type 2;WDR35
615462;Short rib-polydactyly syndrome, Verma-Naumoff type, Short rib-polydactyly syndrome (Jeune's syndrome) type 8;WDR60
616144;Galloway-Mowat syndrome;WDR73
606201;Wolfram syndrome type 1;WFS1
605232;Pseudohypoaldosteronism, type 2c;WNK1
601844;Pseudohypoaldosteronism, type 2b;WNK4
165330;Tetraamelia-multiple malformations syndrome;WNT3
603490;SERKAL syndrome Mullerian aplasia and hyperandrogenism;WNT4
164975;Robinow syndrome, autosomal dominant 1;WNT5A
601570;Ulna and fibula, absense of, with severe limb deficiency;WNT7A
607102;Denys-Drash syndrome, Frasier syndrome, Nephrotic syndrome type 4, Wilms tumor type 1;WT1
607633;Xanthinuria, type i;XDH
613553;Nephronophthisis-like nephropathy 1;XPNPEP3
194363;Short stature, microcephaly, and endocrine dysfunction;XRCC4
608125;Spondylocular syndrome;XYLT2
606608;Coloboma, ocular, Coloboma, ocular, with or without hearing impairment, cleft lip palate, and or mental retardation;YAP1
176947;Autoimmune Disease, multisystem, infantile-onset, 2;ZAP70
300265;VACTERL association, X-linked Heterotaxy, visceral, 1;ZIC3
606480;Restrictive Dermopathy, Lethal;ZMPSTE24
604557;Nephronophthisis-14 Joubert syndrome 16;ZNF423
610568;Paget disease of bone 6;ZNF687
